CDO AI Forum – Chicago – Westin Chicago River North – June 22, 2026 Join top AI and Data leaders in Chicago to explore the strategies, governance, and innovations driving enterprise performance. Connect, learn, and gain actionable insights — reserve your seat today.
The State of AI Reliability: Why Trust Is Becoming the Biggest Barrier to Scaling AI AI adoption is accelerating across the enterprise, but reliability is lagging. In a new research report, The State of AI Reliability: Perspectives from Data & AI Leaders, CDO Magazine, in partnership...
CDO Magazine Announces the Top 30 Healthcare Innovators 2026 Across healthcare, AI has moved from experimentation to enterprise execution. CDO Magazine recognizes the Top 30 Healthcare Innovators 2026 who are turning that shift into measurable impact. This year...
Leadership
Daiichi Sankyo, Head of Data Governance, R&D: Significance of Data in Drug Development Life Cycle2
Written by: CDO Magazine
Updated 3:50 AM EST, November 27, 2023
(USA and Canada) Hayes Williams, Head of Data Governance, R&D at Daiichi Sankyo, together with Baz Khuti, President US at Modak, explains the importance of data in his role as a CDO. Williams’ responsibilities in research and development are fully invested in data. From the beginning of basic research to managing clinical trials, quality data management and governance are essential across the company. The overall life cycle of drug development highlights data as a strategic asset in providing the best drug treatments for patients.
Elevate Your Personal Brand
